Table of Contents 1 Biosimilar Monoclonal Antibodies Market Overview 1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies 1.2 Biosimilar Monoclonal Antibodies Segment by Type 1.2.1 Global Biosimilar Monoclonal Antibodies Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Infliximab 1.2.3 Rituximab 1.2.4 Trastuzumab 1.2.5 Adalimumab 1.2.6 Other 1.3 Biosimilar Monoclonal Antibodies Segment by Application 1.3.1 Biosimilar Monoclonal Antibodies Sales Comparison by Application: 2020 VS 2026 1.3.2 Oncology 1.3.3 Autoimmune Disease 1.3.4 Other 1.4 Global Biosimilar Monoclonal Antibodies Market Size Estimates and Forecasts 1.4.1 Global Biosimilar Monoclonal Antibodies Revenue 2015-2026 1.4.2 Global Biosimilar Monoclonal Antibodies Sales 2015-2026 1.4.3 Biosimilar Monoclonal Antibodies Market Size by Region: 2020 Versus 2026 2 Global Biosimilar Monoclonal Antibodies Market Competition by Manufacturers 2.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020) 2.2 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020) 2.3 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type 2.5 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends 2.5.1 Biosimilar Monoclonal Antibodies Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Biosimilar Monoclonal Antibodies Players (Opinion Leaders) 3 Biosimilar Monoclonal Antibodies Retrospective Market Scenario by Region 3.1 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country 3.3.1 North America Biosimilar Monoclonal Antibodies Sales by Country 3.3.2 North America Biosimilar Monoclonal Antibodies Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures by Country 3.4.1 Europe Biosimilar Monoclonal Antibodies Sales by Country 3.4.2 Europe Biosimilar Monoclonal Antibodies Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Biosimilar Monoclonal Antibodies Market Facts & Figures by Region 3.5.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region 3.5.2 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country 3.6.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country 3.6.2 Latin America Biosimilar Monoclonal Antibodies Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Biosimilar Monoclonal Antibodies Market Facts & Figures by Country 3.7.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country 3.7.2 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Biosimilar Monoclonal Antibodies Historic Market Analysis by Type 4.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020) 4.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2015-2020) 4.3 Global Biosimilar Monoclonal Antibodies Price Market Share by Type (2015-2020) 4.4 Global Biosimilar Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Biosimilar Monoclonal Antibodies Historic Market Analysis by Application 5.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020) 5.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2015-2020) 5.3 Global Biosimilar Monoclonal Antibodies Price by Application (2015-2020) 6 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business 6.1 Celltrion 6.1.1 Corporation Information 6.1.2 Celltrion Description, Business Overview and Total Revenue 6.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Celltrion Products Offered 6.1.5 Celltrion Recent Development 6.2 Pfizer (Hospira) 6.2.1 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.2.2 Pfizer (Hospira) Description, Business Overview and Total Revenue 6.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer (Hospira) Products Offered 6.2.5 Pfizer (Hospira) Recent Development 6.3 3SBIO 6.3.1 3SBIO Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.3.2 3SBIO Description, Business Overview and Total Revenue 6.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.3.4 3SBIO Products Offered 6.3.5 3SBIO Recent Development 6.4 Novartis (Sandoz) 6.4.1 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.4.2 Novartis (Sandoz) Description, Business Overview and Total Revenue 6.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Novartis (Sandoz) Products Offered 6.4.5 Novartis (Sandoz) Recent Development 6.5 Dr Reddy’s 6.5.1 Dr Reddy’s Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.5.2 Dr Reddy’s Description, Business Overview and Total Revenue 6.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Dr Reddy’s Products Offered 6.5.5 Dr Reddy’s Recent Development 6.6 Celgen Biopharma 6.6.1 Celgen Biopharma Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.6.2 Celgen Biopharma Description, Business Overview and Total Revenue 6.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Celgen Biopharma Products Offered 6.6.5 Celgen Biopharma Recent Development 6.7 Cadila Healthcare 6.6.1 Cadila Healthcare Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.6.2 Cadila Healthcare Description, Business Overview and Total Revenue 6.6.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Cadila Healthcare Products Offered 6.7.5 Cadila Healthcare Recent Development 6.8 Hisun Pharma 6.8.1 Hisun Pharma Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.8.2 Hisun Pharma Description, Business Overview and Total Revenue 6.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Hisun Pharma Products Offered 6.8.5 Hisun Pharma Recent Development 6.9 Torrent Pharmaceuticals 6.9.1 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Sites and Area Served 6.9.2 Torrent Pharmaceuticals Description, Business Overview and Total Revenue 6.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Torrent Pharmaceuticals Products Offered 6.9.5 Torrent Pharmaceuticals Recent Development 7 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis 7.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies 7.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Biosimilar Monoclonal Antibodies Distributors List 8.3 Biosimilar Monoclonal Antibodies Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Biosimilar Monoclonal Antibodies Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Type (2021-2026) 10.2 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Application (2021-2026) 10.3 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Region (2021-2026) 10.4 North America Biosimilar Monoclonal Antibodies Estimates and Projections (2021-2026) 10.5 Europe Biosimilar Monoclonal Antibodies Estimates and Projections (2021-2026) 10.6 Asia Pacific Biosimilar Monoclonal Antibodies Estimates and Projections (2021-2026) 10.7 Latin America Biosimilar Monoclonal Antibodies Estimates and Projections (2021-2026) 10.8 Middle East and Africa Biosimilar Monoclonal Antibodies Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Biosimilar Monoclonal Antibodies Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Biosimilar Monoclonal Antibodies Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Biosimilar Monoclonal Antibodies Manufacturers Covered in This Study Table 5. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2015-2020) Table 7. Global Biosimilar Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Biosimilar Monoclonal Antibodies Sales Sites and Area Served Table 11. Manufacturers Biosimilar Monoclonal Antibodies Product Types Table 12. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Biosimilar Monoclonal Antibodies Players Table 16. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Region (2015-2020) Table 17. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020) Table 18. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) by Region (2015-2020) Table 19. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020) Table 20. North America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units) Table 21. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020) Table 22. North America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million) Table 23. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020) Table 24. Europe Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units) Table 25. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020) Table 26. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020) Table 32. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units) Table 33. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020) Table 34. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020) Table 40. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020) Table 41. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2015-2020) Table 42. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) by Type (2015-2020) Table 43. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2015-2020) Table 44. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2015-2020) Table 45. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020) Table 46. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020) Table 47. Global Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2015-2020) Table 48. Celltrion Biosimilar Monoclonal Antibodies Corporation Information Table 49. Celltrion Description and Business Overview Table 50. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Celltrion Main Product Table 52. Celltrion Recent Development Table 53. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Corporation Information Table 54. Pfizer (Hospira) Corporation Information Table 55. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Pfizer (Hospira) Main Product Table 57. Pfizer (Hospira) Recent Development Table 58. 3SBIO Biosimilar Monoclonal Antibodies Corporation Information Table 59. 3SBIO Corporation Information Table 60. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. 3SBIO Main Product Table 62. 3SBIO Recent Development Table 63. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Corporation Information Table 64. Novartis (Sandoz) Corporation Information Table 65. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Novartis (Sandoz) Main Product Table 67. Novartis (Sandoz) Recent Development Table 68. Dr Reddy’s Biosimilar Monoclonal Antibodies Corporation Information Table 69. Dr Reddy’s Corporation Information Table 70. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Dr Reddy’s Main Product Table 72. Dr Reddy’s Recent Development Table 73. Celgen Biopharma Biosimilar Monoclonal Antibodies Corporation Information Table 74. Celgen Biopharma Corporation Information Table 75. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Celgen Biopharma Main Product Table 77. Celgen Biopharma Recent Development Table 78. Cadila Healthcare Biosimilar Monoclonal Antibodies Corporation Information Table 79. Cadila Healthcare Corporation Information Table 80. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Cadila Healthcare Main Product Table 82. Cadila Healthcare Recent Development Table 83. Hisun Pharma Biosimilar Monoclonal Antibodies Corporation Information Table 84. Hisun Pharma Corporation Information Table 85. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Hisun Pharma Main Product Table 87. Hisun Pharma Recent Development Table 88. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Corporation Information Table 89. Torrent Pharmaceuticals Corporation Information Table 90. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Torrent Pharmaceuticals Main Product Table 92. Torrent Pharmaceuticals Recent Development Table 93. Sales Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Biosimilar Monoclonal Antibodies Distributors List Table 96. Biosimilar Monoclonal Antibodies Customers List Table 97. Market Key Trends Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 99. Key Challenges Table 100. Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Type (2021-2026) Table 101. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2021-2026) Table 102. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) Forecast by Type (2021-2026) Table 103. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 104. Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Application (2021-2026) Table 105. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) Forecast by Application (2021-2026) Table 106. Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Region (2021-2026) Table 107. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2021-2026) Table 108. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2021-2026) (US$ Million) Table 109. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Region (2021-2026) Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Biosimilar Monoclonal Antibodies Figure 2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type: 2020 VS 2026 Figure 3. Infliximab Product Picture Figure 4. Rituximab Product Picture Figure 5. Trastuzumab Product Picture Figure 6. Adalimumab Product Picture Figure 7. Other Product Picture Figure 8. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application: 2020 VS 2026 Figure 9. Oncology Figure 10. Autoimmune Disease Figure 11. Other Figure 12. Global Biosimilar Monoclonal Antibodies Market Size 2015-2026 (US$ Million) Figure 13. Global Biosimilar Monoclonal Antibodies Sales Capacity (K Units) (2015-2026) Figure 14. Global Biosimilar Monoclonal Antibodies Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Biosimilar Monoclonal Antibodies Sales Share by Manufacturers in 2020 Figure 16. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Biosimilar Monoclonal Antibodies Revenue in 2019 Figure 18. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020) Figure 20. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2019 Figure 21. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020) Figure 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2019 Figure 23. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019 Figure 24. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019 Figure 25. U.S. Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 26. U.S. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 28. Canada Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019 Figure 30. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019 Figure 31. Germany Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 32. Germany Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 34. France Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 36. U.K. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 38. Italy Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 40. Russia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2019 Figure 42. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2019 Figure 43. China Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 44. China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 46. Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 48. South Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 50. India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 52. Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 54. Taiwan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 56. Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 58. Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 60. Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 62. Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 64. Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019 Figure 66. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019 Figure 67. Mexico Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 68. Mexico Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 70. Brazil Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 72. Argentina Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019 Figure 75. Turkey Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 76. Turkey Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 78. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units) Figure 80. U.A.E Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2015-2020) Figure 82. Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2019 Figure 83. Revenue Share of Biosimilar Monoclonal Antibodies by Type (2015-2020) Figure 84. Revenue Market Share of Biosimilar Monoclonal Antibodies by Type in 2019 Figure 85. Global Biosimilar Monoclonal Antibodies Sales Growth by Type (2015-2020) (K Units) Figure 86. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020) Figure 87. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Biosimilar Monoclonal Antibodies by Application (2015-2020) Figure 89. Global Revenue Share of Biosimilar Monoclonal Antibodies by Application in 2020 Figure 90. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. 3SBIO Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Novartis (Sandoz) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Dr Reddy’s Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Celgen Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Cadila Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Hisun Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Price Trend of Key Raw Materials Figure 100. Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies Figure 101. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies Figure 102. Biosimilar Monoclonal Antibodies Industrial Chain Analysis Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. North America Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. North America Biosimilar Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Europe Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Europe Biosimilar Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Biosimilar Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Biosimilar Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

Celltrion Pfizer (Hospira) 3SBIO Novartis (Sandoz) Dr Reddy’s Celgen Biopharma Cadila Healthcare Hisun Pharma Torrent Pharmaceuticals